- Home
- DRUG vs PROF Comparison
DRUG vs PROF Comparison
Compare DRUG & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- PROF
- Stock Information
- Founded
- DRUG 2019
- PROF N/A
- Country
- DRUG United States
- PROF Canada
- Employees
- DRUG N/A
- PROF N/A
- Industry
- DRUG Pharmaceuticals and Biotechnology
- PROF Medical/Dental Instruments
- Sector
- DRUG Health Care
- PROF Health Care
- Exchange
- DRUG Nasdaq
- PROF Nasdaq
- Market Cap
- DRUG 260.6M
- PROF 225.5M
- IPO Year
- DRUG N/A
- PROF N/A
- Fundamental
- Price
- DRUG $39.85
- PROF $7.79
- Analyst Decision
- DRUG Buy
- PROF Strong Buy
- Analyst Count
- DRUG 1
- PROF 2
- Target Price
- DRUG $75.00
- PROF $11.40
- AVG Volume (30 Days)
- DRUG 89.2K
- PROF 126.8K
- Earning Date
- DRUG 02-11-2025
- PROF 11-07-2024
- Dividend Yield
- DRUG N/A
- PROF N/A
- EPS Growth
- DRUG N/A
- PROF N/A
- EPS
- DRUG N/A
- PROF N/A
- Revenue
- DRUG N/A
- PROF $8,984,000.00
- Revenue This Year
- DRUG N/A
- PROF $56.61
- Revenue Next Year
- DRUG N/A
- PROF $160.87
- P/E Ratio
- DRUG N/A
- PROF N/A
- Revenue Growth
- DRUG N/A
- PROF 39.35
- 52 Week Low
- DRUG $0.93
- PROF $6.78
- 52 Week High
- DRUG $79.02
- PROF $11.42
- Technical
- Relative Strength Index (RSI)
- DRUG 51.96
- PROF 56.04
- Support Level
- DRUG $34.29
- PROF $6.78
- Resistance Level
- DRUG $42.47
- PROF $7.99
- Average True Range (ATR)
- DRUG 3.54
- PROF 0.36
- MACD
- DRUG -0.04
- PROF 0.08
- Stochastic Oscillator
- DRUG 61.03
- PROF 83.47
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.